Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam S Feldman

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
World Journal of Urology|January 20, 2024
The effect of limited english proficiency on prostate-specific antigen screening in American menBenjamin V Stone, Muhieddine Labban, Edoardo Beatrici, et al.
European Urology|January 2, 2017
Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing TherapyRoss E Krasnow, Michael Drumm, Hannah J Roberts, et al.
Magnetic Resonance in Chemistry : MRC|September 1, 2023
Differentiation of patients with and without prostate cancer using urine <sup>1</sup> H NMR metabolomicsAnna-Laura Hasubek, Xiaoyu Wang, Ella Zhang, et al.
European Urology|January 14, 2017
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital ExperienceNicholas J Giacalone, William U Shipley, Rebecca H Clayman, et al.
Oncotarget|February 9, 2018
Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cellsLucas Tricoli, Aisha Naeem, Erika Parasido, et al.
European Urology Focus|August 28, 2023
Corrigendum to "Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes" [Eur. Urol. Focus (2023)]Jennifer Linehan, Josh Gottlieb, Solomon L Woldu, et al.
European Urology Focus|June 1, 2023
Route of Administration for UGN-101 and Impact on Oncological and Safety OutcomesJennifer Linehan, Josh Gottlieb, Solomon L Woldu, et al.
Urologic Oncology|May 28, 2023
The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinomaHristos Z Kaimakliotis, Isamu Tachibana, Solomon Woldu, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2016
Quality of Life in Long-term Survivors of Muscle-Invasive Bladder CancerKimberley S Mak, Angela B Smith, Alec Eidelman, et al.
Radiology|October 24, 2023
Gadolinium-based Contrast Agent Biodistribution and Speciation in RatsMariane Le Fur, Brianna F Moon, Iris Y Zhou, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
World Journal of Urology|January 20, 2024
The effect of limited english proficiency on prostate-specific antigen screening in American menBenjamin V Stone, Muhieddine Labban, Edoardo Beatrici, et al.
European Urology|January 2, 2017
Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing TherapyRoss E Krasnow, Michael Drumm, Hannah J Roberts, et al.
Magnetic Resonance in Chemistry : MRC|September 1, 2023
Differentiation of patients with and without prostate cancer using urine <sup>1</sup> H NMR metabolomicsAnna-Laura Hasubek, Xiaoyu Wang, Ella Zhang, et al.
European Urology|January 14, 2017
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital ExperienceNicholas J Giacalone, William U Shipley, Rebecca H Clayman, et al.
Oncotarget|February 9, 2018
Characterization of the effects of defined, multidimensional culture conditions on conditionally reprogrammed primary human prostate cellsLucas Tricoli, Aisha Naeem, Erika Parasido, et al.
European Urology Focus|August 28, 2023
Corrigendum to "Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes" [Eur. Urol. Focus (2023)]Jennifer Linehan, Josh Gottlieb, Solomon L Woldu, et al.
European Urology Focus|June 1, 2023
Route of Administration for UGN-101 and Impact on Oncological and Safety OutcomesJennifer Linehan, Josh Gottlieb, Solomon L Woldu, et al.
Urologic Oncology|May 28, 2023
The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinomaHristos Z Kaimakliotis, Isamu Tachibana, Solomon Woldu, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2016
Quality of Life in Long-term Survivors of Muscle-Invasive Bladder CancerKimberley S Mak, Angela B Smith, Alec Eidelman, et al.
Radiology|October 24, 2023
Gadolinium-based Contrast Agent Biodistribution and Speciation in RatsMariane Le Fur, Brianna F Moon, Iris Y Zhou, et al.
Pageof 11